Traders Sell iShares NASDAQ Biotechnology Index (IBB) on Strength (IBB)

Investors sold shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) on strength during trading on Tuesday. $60.37 million flowed into the stock on the tick-up and $111.24 million flowed out of the stock on the tick-down, for a money net flow of $50.87 million out of the stock. Of all equities tracked, iShares NASDAQ Biotechnology Index had the 25th highest net out-flow for the day. iShares NASDAQ Biotechnology Index traded up $2.04 for the day and closed at $110.41

The firm has a market cap of $10,290.00, a PE ratio of 3.65 and a beta of 1.38.

The business also recently disclosed a quarterly dividend, which was paid on Thursday, December 28th. Stockholders of record on Friday, December 22nd were given a dividend of $0.125 per share. The ex-dividend date of this dividend was Thursday, December 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.45%. This is a boost from iShares NASDAQ Biotechnology Index’s previous quarterly dividend of $0.04. iShares NASDAQ Biotechnology Index’s dividend payout ratio (DPR) is 2.38%.

Several institutional investors have recently bought and sold shares of the company. Clal Insurance Enterprises Holdings Ltd raised its position in shares of iShares NASDAQ Biotechnology Index by 175.5% during the 3rd quarter. Clal Insurance Enterprises Holdings Ltd now owns 635,875 shares of the financial services provider’s stock valued at $212,132,000 after buying an additional 405,091 shares in the last quarter. Quantitative Investment Management LLC purchased a new stake in shares of iShares NASDAQ Biotechnology Index during the 2nd quarter valued at $103,504,000. Ameriprise Financial Inc. raised its position in shares of iShares NASDAQ Biotechnology Index by 9.3% during the 3rd quarter. Ameriprise Financial Inc. now owns 101,917 shares of the financial services provider’s stock valued at $33,991,000 after buying an additional 8,667 shares in the last quarter. Williams Jones & Associates LLC raised its position in shares of iShares NASDAQ Biotechnology Index by 91.0% during the 2nd quarter. Williams Jones & Associates LLC now owns 92,556 shares of the financial services provider’s stock valued at $28,700,000 after buying an additional 44,096 shares in the last quarter. Finally, Tudor Investment Corp ET AL purchased a new stake in shares of iShares NASDAQ Biotechnology Index during the 2nd quarter valued at $24,186,000. Hedge funds and other institutional investors own 21.10% of the company’s stock.

TRADEMARK VIOLATION WARNING: This story was originally published by BBNS and is the property of of BBNS. If you are viewing this story on another domain, it was illegally stolen and republished in violation of US and international copyright and trademark legislation. The original version of this story can be read at https://baseballnewssource.com/markets/traders-sell-ishares-nasdaq-biotechnology-index-ibb-on-strength-ibb/1821628.html.

About iShares NASDAQ Biotechnology Index

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Houston Astros Add Starter to Rotation
Houston Astros Add Starter to Rotation
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Justin Morneau Former Star With Twins and AL MVP Retires
Justin Morneau Former Star With Twins and AL MVP Retires
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets


Leave a Reply

 
© 2006-2018 BBNS.